CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 170 filers reported holding CLOVIS ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $667,000 | -20.6% | 560,565 | +20.1% | 0.00% | – |
| Q2 2022 | $840,000 | -10.8% | 466,652 | 0.0% | 0.00% | – |
| Q1 2022 | $942,000 | -19.9% | 466,652 | +7.5% | 0.00% | – |
| Q4 2021 | $1,176,000 | +278.1% | 433,983 | +1355.7% | 0.00% | – |
| Q4 2019 | $311,000 | +63.7% | 29,812 | -38.5% | 0.00% | – |
| Q3 2019 | $190,000 | -80.1% | 48,482 | -24.5% | 0.00% | – |
| Q2 2019 | $955,000 | +112.7% | 64,218 | +254.9% | 0.00% | – |
| Q1 2019 | $449,000 | -16.1% | 18,095 | -0.7% | 0.00% | – |
| Q3 2018 | $535,000 | -66.1% | 18,215 | -39.1% | 0.00% | – |
| Q1 2018 | $1,579,000 | +241.8% | 29,911 | +9103.4% | 0.00% | – |
| Q4 2017 | $462,000 | -99.5% | 325 | -100.0% | 0.00% | -100.0% |
| Q1 2017 | $84,788,000 | +14594.6% | 1,331,669 | +10143.6% | 0.02% | – |
| Q4 2016 | $577,000 | -91.6% | 13,000 | -93.2% | 0.00% | -100.0% |
| Q3 2016 | $6,890,000 | – | 191,122 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
| Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
| Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
| Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
| Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
| Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
| Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
| SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
| Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |